The global skincare market is fast growing and expansive, ranging from cosmetic products, to over-the-counter drugs, to prescription drugs. The global dermatology market (OTC and prescription) is vast and evolving quickly with forecasts that indicate a global market of €81.9 billion in 2028, growing significantly from €44.1 billion in 2018. The cosmetic skincare market size was valued at €130 billion in 2016.


The cosmetic skincare market is dominated by key multinational corporations including Olay, Avon, and L’Oréal, which provide a vast array of over-the-counter products in the beauty and skincare industry. The global dermatology market focuses on a combination of OTC and prescription products, which treat acne, psoriasis, alopecia, skin infections, skin cancer, rosacea, and atopic dermatitis.


Irish Research company GMR Data just published their biennial report that outlines this key market, detailing which areas are set to grow and why.

 See the rest of this blog here -

GMR Data produce bespoke and off-the-shelf business reports across the Pharmaceutical, Energy / Utility and IT sectors. Proud to be an Irish business in the gloabl market place.